September 06, 2017
A Delaware federal judge dealt a blow to Mallinckrodt in a patent suit against Praxair on Tuesday, when he ruled that several patents covering the respiratory drug Inomax were invalid for claiming only natural phenomena, and found other patents were not infringed.